Clinical Trials Browser

Phase 1/2 × Leukemia × Homoharringtonine × Clear all

NCT00030355 2013-03-22

Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia

Phase 1/2 Withdrawn

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute